PanTHERA CryoSolutions

Edmonton, Canada Founded: 2018 • Age: 8 yrs Acquired By BioLife Solutions
Cryopreservation platform for cells, tissues, and organs is provided.
Annual revenue - Latest available
Total funding $6.0M 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors 11 Brand Intelligence

About PanTHERA CryoSolutions

PanTHERA CryoSolutions is a company based in Edmonton (Canada) founded in 2018 by Jason Acker and Robert Ben was acquired by BioLife Solutions in April 2025. PanTHERA CryoSolutions has raised $6 million across 2 funding rounds from investors including BioLife Solutions and Casdin Capital. PanTHERA CryoSolutions offers products and services including Ice Recrystallization Inhibitors. PanTHERA CryoSolutions operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

  • Headquarter Edmonton, Canada
  • Founders Jason Acker, Robert Ben
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $6 M (USD)

    in 2 rounds

  • Latest Funding Round
    $4 M (USD), Series A

    Jan 25, 2021

  • Investors
  • Employee Count
    Not available
  • Acquired by
    BioLife Solutions

    (Apr 07, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PanTHERA CryoSolutions

PanTHERA CryoSolutions offers a comprehensive portfolio of products and services, including Ice Recrystallization Inhibitors.

Product name locked
Category locked
Primary

Products that reduce ice damage and improve cell recovery in freezing processes.

People of PanTHERA CryoSolutions

Headcount 1-10
Employee Profiles 5
Board Members and Advisors 3
Employee Profiles
People
Jason Acker
President & CEO
People
Ilias Mahmud
Senior R&D Synthetic Organic Chemist
People
Robert Ben
Chief Scientific Officer
People
Jasper Quartus
Synthetic Organic Chemist

Unlock access to complete

Board Members and Advisors
people
Peter Lee
Board Member
people
Aby Mathew
Board Member
people
Erik Woods
Board Member

Unlock access to complete

Funding Insights of PanTHERA CryoSolutions

PanTHERA CryoSolutions has successfully raised a total of $6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in PanTHERA CryoSolutions

PanTHERA CryoSolutions has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BioLife Solutions and Casdin Capital.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investing in Life Sciences sectors like Healthcare and Biotechnology.
Locked Locked Locked
Tissue hypothermic storage and cryopreservation freeze media are developed.
Locked Locked Locked
Premium access

Investor details for PanTHERA CryoSolutions

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PanTHERA CryoSolutions

Investments
Premium access

Investment portfolio details for PanTHERA CryoSolutions

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PanTHERA CryoSolutions

Premium access

Detailed financials for PanTHERA CryoSolutions

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Panthera Cryosolutions Comparisons

PanTHERA CryoSolutions Primary company
Description
Cryopreservation platform for cells, tissues, and organs is ...
Location
Edmonton, Canada
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for PanTHERA CryoSolutions

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PanTHERA CryoSolutions

PanTHERA CryoSolutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Vacuum robots for semiconductor wafer handling are developed.
Locked Locked Locked
Cold storage solutions for organ transplant preservation are provided.
Locked Locked Locked
Technologies for blood and product storage are developed.
Locked Locked Locked
Technology for cell storage and transportation is developed.
Locked Locked Locked
Portable devices for cell storage and transport are provided.
Locked Locked Locked
Thermal packaging solutions and cold chain monitoring services are provided.
Premium access

Detailed competitors of PanTHERA CryoSolutions

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Panthera Cryosolutions

Premium access

Complete news archive for PanTHERA CryoSolutions

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PanTHERA CryoSolutions

PanTHERA CryoSolutions was founded in 2018 and raised its 1st funding round 2 years after it was founded.

PanTHERA CryoSolutions is headquartered in Edmonton, Canada. It is registered at Edmonton, Alberta, Canada.

PanTHERA CryoSolutions is a funded company, having raised a total of $6M across 2 funding rounds to date.

PanTHERA CryoSolutions was founded in 2018 in Edmonton, Canada, within the biotechnology sector. Technology for cryopreserving cells, tissues, and organs is offered through a patented small molecule ice crystal inhibitor (IRI). Cellular function is preserved during prolonged frozen storage, with reductions in toxicity, stress, and ice crystal development. Dependence on DMSO, liquid nitrogen, and sample thawing is decreased in biological applications.

PanTHERA CryoSolutions's top competitors include Brooks Automation, Hemanext and Bridge to Life.

PanTHERA CryoSolutions offers Ice Recrystallization Inhibitors.

PanTHERA CryoSolutions has 2 investors. Key investors include BioLife Solutions, and Casdin Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available